Search Results - "Finsterer, Josef"

Refine Results
  1. 1

    Congenital myasthenic syndromes by Finsterer, Josef

    Published in Orphanet journal of rare diseases (26-02-2019)
    “…Congenital myasthenic syndromes (CMSs) are a genotypically and phenotypically heterogeneous group of neuromuscular disorders, which have in common an impaired…”
    Get full text
    Journal Article
  2. 2

    Triggers of Guillain-Barré Syndrome: Campylobacter jejuni Predominates by Finsterer, Josef

    “…Guillain-Barré syndrome (GBS) is a rare immune-mediated acute polyradiculo-neuropathy that typically develops after a previous gastrointestinal or respiratory…”
    Get full text
    Journal Article
  3. 3

    Mitochondrial metabolic stroke: Phenotype and genetics of stroke-like episodes by Finsterer, Josef

    Published in Journal of the neurological sciences (15-05-2019)
    “…Stroke-like episodes (SLEs) are the hallmark of mitochondrial encephalopathy with lactic acidosis and stroke-like episode (MELAS) syndrome but rarely occur…”
    Get full text
    Journal Article
  4. 4

    Biomarkers of peripheral muscle fatigue during exercise by Finsterer, Josef

    Published in BMC musculoskeletal disorders (08-11-2012)
    “…Biomarkers of peripheral muscle fatigue (BPMFs) are used to offer insights into mechanisms of exhaustion during exercise in order to detect abnormal fatigue or…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Toxicity of Antiepileptic Drugs to Mitochondria by Finsterer, Josef

    Published in Handbook of experimental pharmacology (01-01-2017)
    “…Some of the side and beneficial effects of antiepileptic drugs (AEDs) are mediated via the influence on mitochondria. This is of particular importance in…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Exacerbating Guillain–Barré Syndrome Eight Days after Vector-Based COVID-19 Vaccination by Finsterer, Josef

    Published in Case reports in infectious diseases (08-05-2021)
    “…Since the introduction of mRNA technology-based and vector-based COVID-19 vaccines, adverse reactions to these agents have been occasionally reported…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20